174 related articles for article (PubMed ID: 2995014)
21. Vitamin D metabolism and the response to 1,25-dihydroxycholecalciferol in Osteoporosis.
Davies M; Mawer EB; Adams PH
J Clin Endocrinol Metab; 1977 Aug; 45(2):199-208. PubMed ID: 195972
[TBL] [Abstract][Full Text] [Related]
22. Alterations in serum and urine parameters reflecting bone turnover in uremic patients during treatment with 1,25-dihydroxyvitamin D3 and 24,25-dihydroxyvitamin D3.
Mortensen BM; Gordeladze JO; Lyngdal PT; Aarseth HP; Gautvik KM
Miner Electrolyte Metab; 1993; 19(2):78-85. PubMed ID: 8377728
[TBL] [Abstract][Full Text] [Related]
23. Treatment of senile osteoporosis with 1alpha-hydroxyvitamin D3.
Sørensen OH; Andersen RB; Christensen MS; Friis T; Hjorth L; Jørgensen FS; Lund B; Melsen F; Mosekilde L
Clin Endocrinol (Oxf); 1977 Dec; 7 Suppl():169s-175s. PubMed ID: 342143
[TBL] [Abstract][Full Text] [Related]
24. Serum 1,25-dihydroxycholecalciferol in anephric, haemodialyzed and kidney-transplanted patients. Effect of vitamin D3 supplement.
Lund B; Clausen E; Friedberg M; Lund B; Moszkowicz M; Nielsen SP; Sørensen OH
Nephron; 1980; 25(1):30-3. PubMed ID: 6243405
[TBL] [Abstract][Full Text] [Related]
25. Treatment of osteoporosis with 1-alpha-hydroxycholecalciferol and calcium.
Hoikka V; Alhava EM; Aro A; Karjalainen P; Rehnberg V
Acta Med Scand; 1980; 207(3):221-4. PubMed ID: 6989171
[TBL] [Abstract][Full Text] [Related]
26. [Treatment of secondary hyperparathyroidism with vitamin D metabolites].
Stojimirović B; Pejanović S; Djukanović Lj
Srp Arh Celok Lek; 1994; 122(7-8):197-9. PubMed ID: 17974384
[TBL] [Abstract][Full Text] [Related]
27. Decreased renal function in association with administration of 1,25-dihydroxyvitamin D3 to patients with stable, advanced renal failure.
Christiansen C; Røodbro P; Christensen MS; Naestoft J; Hartnack B; Transbøol I
Contrib Nephrol; 1980; 18():139-46. PubMed ID: 6243527
[TBL] [Abstract][Full Text] [Related]
28. Comparison of 1 alpha-OH-vitamin D3 and high doses of calcium carbonate for the control of hyperparathyroidism and hyperaluminemia in patients on maintenance dialysis.
Morinière P; Fournier A; Leflon A; Hervé M; Sebert JL; Grégoire I; Bataille P; Guéris J
Nephron; 1985; 39(4):309-15. PubMed ID: 3982576
[TBL] [Abstract][Full Text] [Related]
29. Vitamin D metabolism in pregnant rabbits: differences between the maternal and fetal response to administration of large amounts of vitamin D3.
Kubota M; Ohno J; Shiina Y; Suda T
Endocrinology; 1982 Jun; 110(6):1950-6. PubMed ID: 6280980
[TBL] [Abstract][Full Text] [Related]
30. Postmenopausal osteoporosis: no effect of three years treatment with 1,25-dihydroxycholecalciferol.
Falch JA; Odegaard OR; Finnanger AM; Matheson I
Acta Med Scand; 1987; 221(2):199-204. PubMed ID: 3035879
[TBL] [Abstract][Full Text] [Related]
31. 1-alpha-hydroxycholecalciferol for renal osteodystrophy.
Brownjohn AM; Goodwin FJ; Hately W; Marsh FP; O'Riordan JL; Papapoulos SE
Br Med J; 1977 Sep; 2(6089):721-3. PubMed ID: 912269
[TBL] [Abstract][Full Text] [Related]
32. Bone mineral and calcium metabolism before, during and after treatment of osteoporosis with 1 alpha-hydroxyvitamin D3 and calcium.
Lindholm TS; Eriksson S
Scand J Rheumatol; 1982; 11(1):55-7. PubMed ID: 7063813
[TBL] [Abstract][Full Text] [Related]
33. Some observations on the influence of vitamin D metabolites when added to the diet of commercial laying hens.
Harms RH; Bootwalla SM; Woodward SA; Wilson HR; Untawale GA
Poult Sci; 1990 Mar; 69(3):426-32. PubMed ID: 2345724
[TBL] [Abstract][Full Text] [Related]
34. Effect of estrogen on calcium absorption and serum vitamin D metabolites in postmenopausal osteoporosis.
Gallagher JC; Riggs BL; DeLuca HF
J Clin Endocrinol Metab; 1980 Dec; 51(6):1359-64. PubMed ID: 6255005
[TBL] [Abstract][Full Text] [Related]
35. The ultra long-term treatment of senile osteoporosis with 1 alpha-hydroxyvitamin D3.
Shiraki M; Ito H; Orimo H
Bone Miner; 1993 Mar; 20(3):223-34. PubMed ID: 8490326
[TBL] [Abstract][Full Text] [Related]
36. The effects of intramuscularly administered vitamin D3, 25- and 1 alpha-hydroxycholecalciferol in cows on plasma mineral content, plasma 25-hydroxycholecalciferol and on mineral deposits in soft tissues.
Zepperitz H; Jahreis G; Kiupel H; Hesse V
Zentralbl Veterinarmed A; 1991 Dec; 38(10):763-9. PubMed ID: 1665630
[TBL] [Abstract][Full Text] [Related]
37. Serum ionized calcium, as well as phosphorus and parathyroid hormone, is associated with the plasma 1,25-dihydroxyvitamin D3 concentration in normal postmenopausal women.
Dawson-Hughes B; Harris S; Dallal GE
J Bone Miner Res; 1991 May; 6(5):461-8. PubMed ID: 2068951
[TBL] [Abstract][Full Text] [Related]
38. [Comparative evaluation of the effectiveness of vitamin D3 preparations (1-alpha-hydroxy- and 1-alpha,25-dihydroxycholecalciferol in various forms of osteoporosis and osteomalacia].
Zarubina NA; Rozhinskaia LIa; Bukhman AI; Dorokhova II; Konnova EV
Probl Endokrinol (Mosk); 1989; 35(3):15-9. PubMed ID: 2762260
[TBL] [Abstract][Full Text] [Related]
39. Marked suppression of secondary hyperparathyroidism by intravenous administration of 1,25-dihydroxy-cholecalciferol in uremic patients.
Slatopolsky E; Weerts C; Thielan J; Horst R; Harter H; Martin KJ
J Clin Invest; 1984 Dec; 74(6):2136-43. PubMed ID: 6549016
[TBL] [Abstract][Full Text] [Related]
40. Effects of active vitamin D3 and parathyroid hormone on the serum osteocalcin in idiopathic hypoparathyroidism and pseudohypoparathyroidism.
Mizunashi K; Furukawa Y; Miura R; Yumita S; Sohn HE; Yoshinaga K
J Clin Invest; 1988 Sep; 82(3):861-5. PubMed ID: 2843573
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
